TCT-533 Optimal Excimer Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis. Does debulking matter?

In-stent restenosis (ISR) after femoropopliteal artery stenting is a significant problem occurring in up to 50% of cases. The EXCITE ISR trial aimed to demonstrate that procedural safety and efficacy after debulking ISR lesions with laser atherectomy is superior to balloon angioplasty (PTA) alone.